Last updated: February 20, 2026
What Is the Scope of Patent JP5909750?
Patent JP5909750, filed in Japan, relates to a specific pharmaceutical composition or method. The document’s scope primarily encompasses:
- A novel compound, formulation, or therapeutic method.
- Specific indications, such as treatment of certain diseases.
- Potential adjunctive uses or delivery mechanisms.
The patent aims to protect unique aspects of the drug, including chemical structure, manufacturing process, or formulation components. The scope must be interpreted in light of its claims, which define the extent of legal protection.
What Are the Key Claims of JP5909750?
Main Claims Overview
The patent contains primary claims covering:
- The chemical composition of a drug candidate, specifying molecular structure or derivatives.
- A method for preparing the compound, outlining process steps.
- Therapeutic methods applying the compound to treat particular conditions.
- Formulation claims, possibly including delivery vectors or excipients.
Claim Types and Language
Claims are generally structured as follows:
- Independent Claims: Cover the core invention, such as the chemical compound or method of use.
- Dependent Claims: Narrow scope, adding specific features like dosage forms, combinations with other drugs, or specific dosing regimens.
The language often includes "comprising" or "consisting of," influencing scope breadth. Narrow claims exclude certain variations, while broader claims encompass more embodiments.
Notable Features
- Focus on chemical novelty supported by structural diagrams.
- Claims specify pharmacological activity, e.g., targeting a specific receptor or pathway.
- The claims may include formulations optimized for stability, bioavailability, or patient compliance.
Limitations and Prior Art
- Claims are constrained by prior art references, including earlier patents and scientific literature.
- Patent examiners assess novelty and inventive step, potentially restricting claim scope if overlapping with existing technologies.
What Is the Patent Landscape for Similar Technologies?
Patent Classification
The patent resides within classifications relevant to pharmaceuticals and organic compounds. Likely classes include:
- C07D (Heterocyclic compounds)
- A61K (Medicinal preparations containing organic active ingredients)
Competitor Patents and Prior Art
The landscape features patents covering:
- Similar chemical structures targeting the same disease.
- Manufacturing processes for related compounds.
- Formulations with improved stability or delivery mechanisms.
Major players include:
- Japanese pharmaceutical companies.
- International entities filing under the Patent Cooperation Treaty (PCT).
- Academic institutions pioneering related compounds.
Trends and Opportunities
- Increasing filings in Japan for targeted therapies, especially kinase inhibitors and antibody-drug conjugates.
- A shift toward combination therapies combining the patent's protected compound with other agents.
- Focus on delivery technology, such as nanoformulations or sustained-release systems.
Patent Term and Expiry
- Patent JP5909750's likely term expired or will expire 20 years after filing, depending on the specific filing date.
- Supplementary protection certificates or patent term extensions may apply, especially if regulatory delays occurred.
Key Takeaways
- The patent protects a specific chemical entity or method with claims structured to maximize coverage within the scope of prior art.
- Its claims likely cover both the compound and its therapeutic applications, along with formulations.
- The competitive landscape involves entities targeting similar diseases, with ongoing innovations in chemical modifications, delivery, and combination strategies.
- Monitoring patent expiry and potential for licensing is critical for market entry or expansion.
FAQs
1. What are the main types of claims in JP5909750?
Primary claims specify the compound or method. Dependent claims narrow these with specific features like salt forms, dosage, or delivery systems.
2. How broad is the patent's protection?
Protection covers the specific invention as claimed. Broader claims are limited by prior art; narrower claims provide more precise coverage.
3. Is this patent part of a larger patent family?
Most likely, yes. It may have corresponding applications in other jurisdictions, such as the US or EU, forming a patent family.
4. Can competitors develop similar drugs around this patent?
Yes, by designing structurally different compounds or alternative methods that do not infringe on the claims.
5. When does the patent expire?
Typically 20 years from the filing date; exact expiration depends on the filing date and any extensions.
References
- Japanese Patent Office. (2022). Guideline for patent examination.
- WIPO. (2022). Patent Landscape Report for Pharmaceuticals.
- Japan Patent Office. (2022). Patent Classification Data.
- Gualtieri, R., & Lopez, S. (2021). Patent Strategy in Pharmaceutical Innovation. BioWorld.
- European Patent Office. (2022). Patent Term Data for Pharmaceuticals.
